Streetbeat News

Stock Prices

MRNA

10 analysts have provided varied opinions on Moderna (NASDAQ:MRNA) over the past quarter, with ratings ranging from bullish to bearish. The average 12-month price target has increased by 4.01% to $147.3. Analysts have maintained, raised, or announced new ratings and price targets, reflecting their evolving perceptions of Moderna's market standing. Despite challenges in revenue growth, net margin, ROE, and ROA, Moderna's debt management remains conservative.

Portfolio Pulse from Benzinga Insights

June 27, 2024 | 5:01 pm

CRK

In the past three months, analysts have provided mixed ratings for Comstock Resources (NYSE:CRK), with a range of bullish to bearish perspectives. The average 12-month price target has increased by 7% to $10.7. Despite this, the company faces financial challenges, including a significant revenue decline and below-average profitability metrics.

Portfolio Pulse from Benzinga Insights

June 27, 2024 | 5:01 pm

RUM

Rumble announced an emergency upgrade to increase livestreaming capacity due to anticipated high demand. The company thanked YouTube for its support over the years.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:58 pm

AOGO

Trading for AOGO was halted at 12:54:59 p.m. ET due to pending news. Investors should stay tuned for updates as this could impact the stock's short-term performance.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:55 pm

AOGOW

Trading in AOGOW was halted at 12:55:00 p.m. ET pending news. Investors should stay tuned for updates as trading halts can indicate significant upcoming announcements.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:55 pm

AOGOU

Trading for AOGOU was halted at 12:55:00 p.m. ET due to pending news. Investors should stay alert for further updates.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:55 pm

WS

Worthington Steel shares are trading higher after the company reported better-than-expected Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:54 pm

ZBH

Jenny Harrington announced on CNBC that she has bought more shares of Zimmer Biomet.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:54 pm

APOG

Apogee Enterprises shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results and raised its FY25 adjusted EPS guidance above estimates.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 4:51 pm

CVS

WBA

CVS Health Corp (NYSE:CVS) shares found support at the $57.60 level, a previous resistance point, following a poor earnings report from Walgreens Boots Alliance Inc. (NASDAQ:WBA). This support level could indicate a potential rebound as remorseful sellers place buy orders, creating a floor under the shares.

Portfolio Pulse from Mark Putrino

June 27, 2024 | 4:51 pm